BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  Mallinckrodt Pays $117M for This Bay Area Biotech and Its Failed Liver Drug

  Mallinckrodt has agreed to buy Ocera Therapeutics in a deal that could hit $117M.

  November 2, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Biogen’s Early-Stage Alzheimer’s Data Continues to Impress

  ALZ’s researchers continue to see hope in Biogen’s aducanumab.

  November 2, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  4 Medtech Stocks That Will Top Q3 Earnings

  Here are four players that have the right combination of elements to post an earnings beat this quarter.

  November 2, 2017

   · 

  1 min read
• Business

  Onconova Therapeutics to Provide Corporate Update and Third Quarter 2017 Financial Results

  The Company will host a conference call to discuss these results and provide an update on all rigosertib programs at 9:00 a.m. ET.

  November 2, 2017

   · 

  5 min read
• 

  Drug Development

  Alnylam Emerges as Winner in Rare Disease Study Showdown With Ionis

  Alnylam and Sanofi Genzyme presented positive Phase III results of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy at a conference in France.

  November 2, 2017

   · 

  3 min read

   · 

  Mark Terry
• Business

  Cyclacel Pharmaceuticals to Release Third Quarter 2017 Financial Results

  The Company will host a conference call and live webcast at 4:30 p.m. ET on the same day.

  November 2, 2017

   · 

  3 min read
• 

  Business

  Dicerna Could Pocket $201M in NASH R&D Deal With Boehringer Ingelheim

  Dicerna and Boehringer Ingelheim today announced a research collaboration and license agreement to discover and develop novel RNAi therapeutics for the treatment of chronic liver diseases.

  November 2, 2017

   · 

  4 min read

   · 

  Alex Keown
• 

  Policy

  Sanofi Falls Short of Q3 Expectations, Terminates Phase II Lung Drug From Pipeline

  Despite Brandicourt’s positive spin, investors were displeased as the company’s financial report fell shy of analysts’ expectations.

  November 2, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Engineering Firm, Axiscades, to Open 500-Worker North American HQ in Indiana

  The company plans to invest nearly $10 million over five years to establish operations in Indiana.

  November 2, 2017

   · 

  1 min read
• 

  Coloplast Tanks After New Strategy Disappoints

  Shares of Coloplast are down more than 11 percent this morning after the company presented a new long-term financial guidance that includes a decision to give up on improving its EBIT annually.

  November 2, 2017

   · 

  2 min read

   · 

  Alex Keown